Condition: Fracture Femur · Fracture Tibia · Sponsor: Pharmanutra S.p.a.
This clinical study aims to evaluate the potential benefits of a formulation based on Cetylated Fatty Acids in improving fracture healing of long bones in the lower limbs. The investigational product is administered orally over a 12-week period. Study procedures are limited to standard imaging techniques (radiography and echography), blood sampling, and completion of validated quality of life questionnaires.
This description comes directly from the study's public registry record.
Maria Sole Rossato · +390507846500 · ms.rossato@pharmanutra.it
Always discuss trial participation with your own doctor first.
| AZ Monica | Deurne, Antwerp, Belgium | Recruiting |
| Algemeen Ziekenhuis Herentals | Herentals, Antwerp, Belgium | Recruiting |
| Hôpital Erasme - Cliniques Universitaires de Bruxelles | Brussels, Brussels Capital, Belgium | Recruiting |
| Universitair Ziekenhuis Brussel | Brussels, Brussels Capital, Belgium | Recruiting |
| Universitair Ziekenhuis Gent | Ghent, Flanders, Belgium | Recruiting |
| Ziekenhuis Oost-Limburg | Genk, Limburg, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07299851